Consainsights logo
Mail Us

Animal Model Market — USD 14.3 billion in 2023, Growing to USD 35.53B by 2033 at 9.2% CAGR

This report provides comprehensive insights into the Animal Model market, covering market size, growth trends, and detailed analyses from 2023 to 2033. Key data, industry dynamics, and forecasts will enable stakeholders to make informed decisions.

Key Takeaways

  • Global market expands from $14.30 Billion in 2023 to $35.53 Billion in 2033 at a 9.2% CAGR.
  • North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
  • Europe grows from $4.47 Billion in 2023 to $11.1 Billion in 2033; Asia Pacific advances from $3.08 Billion to $7.65 Billion.
  • Major suppliers include Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences.
  • Applications such as oncology, neurology, immunology, and toxicology underpin sustained demand.

Animal Model Market Report — Executive Summary

North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Animal Model Market Report outlines industry expansion driven by technological advances in model development, ongoing need for preclinical testing, and increased investment across pharma and academic research. Market value rises from $14.30 Billion in 2023 to $35.53 Billion in 2033 at a 9.2% CAGR for the 2023 to 2033 period. North America is the largest region by end-period value, reflecting concentrated research infrastructure and established contract research organizations. Product and application segmentation covers genetically modified and wild-type models across oncology, neurology, immunology, and toxicology. Key vendors such as Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences shape supply-side dynamics. The report integrates expert perspectives and cross-validated secondary data to highlight opportunities and challenges facing suppliers, end users, and service providers throughout the forecast window.

Key Growth Drivers

  1. Advances in genetic engineering enabling more disease-relevant animal models.
  2. Sustained demand for preclinical validation in oncology, neurology, immunology, and toxicology.
  3. Ongoing investment from pharmaceutical companies and academic research funding.
  4. Expansion of contract research services supporting outsourcing of model development and testing.
Metric Value
Study Period 2023 - 2033
2023 Market Size $14.30 Billion
CAGR (2023-2033) 9.2%
2033 Market Size $35.53 Billion
Top Companies Charles River Laboratories, Janvier Labs, Envigo, Taconic Biosciences
Published Date 15 October 2024
Last Modified Date 25 May 2026
 Animal Model Market Report (2023 - 2033)

Animal Model Market Overview

The Animal Model market encompasses a wide range of products used for biomedical research, drug development, and toxicology testing. Animal models play pivotal roles in understanding disease mechanisms, evaluating new therapies, and ensuring safety before human trials. Currently, the market is characterized by a growing demand for alternative models due to ethical concerns, advancements in genetic engineering, and increasing funding from public and private sectors. Key market players are striving to innovate and enhance models for various applications including oncology, neurology, and immunology. Overall, the market landscape is evolving rapidly, fueled by technological advancements and heightened regulatory scrutiny.

Customize Animal Model Market Report market research report

  • Get in-depth analysis of Animal Model market size, growth, and forecasts.
  • Understand Animal Model's regional dynamics and industry-specific trends.
  • Identify potential applications, end-user demand, and growth segments in Animal Model

What is the Market Size & CAGR of Animal Model Market Report market in 2023?

The Animal Model market is reported at $14.30 Billion in 2023 and is forecast to reach $35.53 Billion by 2033, reflecting a 9.2% CAGR for the 2023 to 2033 period. Growth is supported by increased demand for preclinical models across oncology, neurology, immunology, and toxicology, coupled with technological advances in genetic engineering and continued investment from pharmaceutical and academic sectors.

Animal Model Industry Analysis

The Animal Model industry is witnessing robust growth propelled by technological advancements and an increasing number of regulatory guidelines emphasizing the need for animal studies in drug development. The industry comprises biopharmaceutical companies, academic institutions, and contract research organizations (CROs). Factors such as globalization of clinical trials and shifting trend towards personalized medicine have compelled industry players to innovate. Additionally, the advent of CRISPR technology for gene editing has opened new avenues in model development, creating specialized animals that more accurately resemble human diseases, thus accelerating the drug discovery process.

Animal Model Market Segmentation and Scope

The Animal Model market is segmented by species type, model type, end-users, and application areas. By species, the major categories include rodents and non-rodents. By model type, the segmentation includes genetically modified models, wild-type models, and syndromic models. Key end-users of these models are pharmaceutical companies, academic institutions, and CROs, each with distinctive needs tailored to specific research areas. Application areas encompass oncology, neurology, immunology, and toxicology among others. This segmentation underscores the diverse utility of animal models across different fields of research and development.

Tell us your focus area and get a customized research report.

Animal Model Market Report Market Analysis Report by Region

Europe Animal Model Market Report:

Europe grows from $4.47 Billion in 2023 to $11.1 Billion in 2033. Growth is underpinned by robust academic research, regulatory frameworks guiding preclinical testing, and ongoing investment in translational science and model innovation.

Asia Pacific Animal Model Market Report:

Asia Pacific grows from $3.08 Billion in 2023 to $7.65 Billion in 2033. Expansion is driven by rising pharmaceutical R&D activity, expanding clinical research ecosystems, and increasing adoption of outsourced model services.

North America Animal Model Market Report:

North America is largest regional market, rising from $4.6 Billion in 2023 to $11.42 Billion in 2033. This region’s scale reflects established research infrastructure, active pharmaceutical R&D, and a significant presence of contract research organizations supporting model development and testing.

South America Animal Model Market Report:

Latin America grows from $0.53 Billion in 2023 to $1.33 Billion in 2033. Regional progress stems from expanding research programs, growing biotech initiatives, and partnerships with global CROs to support local preclinical studies.

Middle East & Africa Animal Model Market Report:

Middle East and Africa grows from $1.63 Billion in 2023 to $4.04 Billion in 2033. Growth reflects developing research capacity, increased funding for biomedical initiatives, and collaboration with international research organizations.

Tell us your focus area and get a customized research report.

Research Methodology

The study synthesizes primary interviews with industry experts and secondary sources including company reports and publications. Findings were validated through data triangulation and internal expert-led trend analysis.

Animal Model Market Analysis By Species

Global Animal Model Market, By Species Market Analysis (2023 - 2033)

In 2023, rodent models account for a significant market share of 86.28% amounting to $12.34 billion, expected to rise to $30.65 billion by 2033. Non-rodent models currently represent 13.72% of the market, valued at $1.96 billion, with a forecast of $4.87 billion in ten years. The high adoption rates for rodent models stem from their genetic mutability and physiological similarities to humans, making them favorable for preclinical testing.

Animal Model Market Analysis By Type

Global Animal Model Market, By Type Market Analysis (2023 - 2033)

Genetically modified models led the market in 2023, holding a revenue share of 60.55% at approximately $8.66 billion. They are projected to reach $21.51 billion by 2033, fueled by advancements in genetic engineering. Wild-type models, with a 26.74% share translating to $3.82 billion, are projected to grow to $9.50 billion. Syndromic models represent a niche portion at 12.71%, starting at $1.82 billion in 2023 and expected to rise to $4.52 billion.

Animal Model Market Analysis By End User

Global Animal Model Market, By End-User Market Analysis (2023 - 2033)

Pharmaceutical companies dominate the Animal Model market with a significant share of 60.55%, amounting to $8.66 billion in 2023, forecasted to reach $21.51 billion by 2033. Academic institutions hold a 26.74% market share valued at $3.82 billion, projected to grow to $9.50 billion. CROs occupy the remaining 12.71% with $1.82 billion and are expected to reach $4.52 billion within the same timeframe.

Animal Model Market Analysis By Application

Global Animal Model Market, By Application Market Analysis (2023 - 2033)

Oncology is the leading application area, holding a market share of 50.82% at $7.27 billion, escalating to $18.06 billion by 2033. Neurology follows with 24.54%, valued at $3.51 billion, projected to grow to $8.72 billion. Immunology stands at $1.67 billion (11.7% share) in 2023, aiming for $4.16 billion, while toxicology represents 12.94% of the market, starting at $1.85 billion and expected to reach $4.60 billion.

Tell us your focus area and get a customized research report.

Global Market Leaders and Top Companies in Animal Model Industry

Charles River Laboratories:

A leading global provider of animal model services and products, Charles River Laboratories specializes in research models, preclinical testing, and drug development services.

Janvier Labs:

Janvier Labs offers a variety of genetically modified and standard animal models for research, emphasizing the importance of robust animal welfare practices in compliance with regulations.

Envigo:

Envigo provides integrated research services and reliable high-quality animal models, focusing on various applications such as pharmacology, toxicology, and general biology.

Taconic Biosciences:

Taconic Biosciences is recognized for its expertise in breeding and supplying genetically engineered mouse models, catering primarily to the needs of the biopharmaceutical industry.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

FAQs

What is the market size of the Animal Model Market Report in 2023?

The market size in 2023 is $14.30 Billion as reported in the input data, representing the baseline for the 2023 to 2033 forecast period.

How big will the Animal Model Market Report be in 2033?

The projected market size for 2033 is $35.53 Billion, based on the provided forecast covering 2023 to 2033.

What is CAGR of the Animal Model Market Report for the forecast period?

The compounded annual growth rate for the 2023 to 2033 forecast period is 9.2% as specified in the input.

Is there a single fastest Growing region in the Animal Model Market Report market?

No single fastest-growing region is stated for the Animal Model Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.

Which companies are listed as key players?

Top companies cited in the input include Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences.

What are the primary application areas driving demand?

Primary application areas noted are oncology, neurology, immunology, and toxicology, which sustain demand for diverse animal models.

Who are the main end users of animal models?

End users specified include pharmaceutical companies, academic institutions, and contract research organizations as primary consumers of models and services.

How is segmentation presented in the report?

Segment groups provided cover model type, species, end user, and application, listing subsegments such as genetically modified models, wild-type models, rodents, and non-rodents.

What regional markets are included in the analysis?

Regions included are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, each with start and end values supplied in the input facts.

Why might companies outsource to CROs in this market?

Contract research organizations offer specialized model development and testing capabilities, enabling pharmaceutical and academic customers to access expertise and scale resources.